145934-81-2 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrolo[2,3-b]pyridine, 5-chloro-2-methylis used as an intermediate in the synthesis of active pharmaceutical ingredients. Its unique structure and properties contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
1H-Pyrrolo[2,3-b]pyridine, 5-chloro-2-methylis used in the development of new agrochemical products. Its chemical properties make it a valuable component in the creation of innovative pesticides or other agrochemicals that can improve crop protection and yield.
Used in Research and Development:
1H-Pyrrolo[2,3-b]pyridine, 5-chloro-2-methylis utilized in the field of research and development for the exploration of novel organic compounds. Its unique structure offers opportunities for further chemical modifications and the discovery of new compounds with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 145934-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,9,3 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 145934-81:
(8*1)+(7*4)+(6*5)+(5*9)+(4*3)+(3*4)+(2*8)+(1*1)=152
152 % 10 = 2
So 145934-81-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7ClN2/c1-5-2-6-3-7(9)4-10-8(6)11-5/h2-4H,1H3,(H,10,11)
145934-81-2Relevant academic research and scientific papers
1, 7 - DIAZACARBAZOLES AND THEIR USE IN THE TREATMENT OF CANCER
-
Page/Page column 89, (2011/07/07)
The invention relates to 1, 7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk 1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
